BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 19589164)

  • 1. Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.
    Akinleye SO; Falade CO; Ajayi IO
    BMC Pregnancy Childbirth; 2009 Jul; 9():28. PubMed ID: 19589164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.
    Adewole AO; Fawole O; Ajayi I; Yusuf B; Oladimeji A; Waziri E; Nguku P; Ajumobi O
    Pan Afr Med J; 2019; 33():101. PubMed ID: 31489079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania.
    Mubyazi G; Bloch P; Kamugisha M; Kitua A; Ijumba J
    Malar J; 2005 Jul; 4():31. PubMed ID: 16033639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon.
    Diengou NH; Cumber SN; Nkfusai CN; Mbinyui MS; Viyoff VZ; Bede F; Akwah L; Tsoka-Gwegweni JM; Judith AK
    Pan Afr Med J; 2020; 35():42. PubMed ID: 32499857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study.
    Ameh S; Owoaje E; Oyo-Ita A; Kabiru CW; Akpet OEO; Etokidem A; Enembe O; Ekpenyong N
    BMC Pregnancy Childbirth; 2016 May; 16():99. PubMed ID: 27147109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching the unreached: effectiveness and satisfaction with community-directed distribution of sulfadoxine-pyrimethamine for preventing malaria in pregnancy in rural South-East, Nigeria.
    Okedo-Alex IN; Akamike IC; Alo CN; Agu AP; Nzeh CB; Ndukwe CD; Okoro OO; Abateneh DD; Uneke CJ
    Malar J; 2020 Nov; 19(1):394. PubMed ID: 33160375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria.
    Balami AD; Md Said S; Mohd Zulkefli NA; Bachok N; Audu B
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):726. PubMed ID: 33238901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey.
    Okoli CI; Hajizadeh M; Rahman MM; Khanam R
    Malar J; 2021 Jul; 20(1):300. PubMed ID: 34217299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria.
    Amoran OE; Ariba AA; Iyaniwura CA
    Reprod Health; 2012 Aug; 9():12. PubMed ID: 22889320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.
    Arnaldo P; Cambe MI; Magaço A; Chicumbe S; Rovira-Vallbona E; Rosanas-Urgell A; Enosse SM
    PLoS One; 2019; 14(1):e0203740. PubMed ID: 30677039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.
    Marchant T; Nathan R; Jones C; Mponda H; Bruce J; Sedekia Y; Schellenberg J; Mshinda H; Hanson K
    Malar J; 2008 Dec; 7():260. PubMed ID: 19094198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of intermittent preventive treatment for malaria in pregnancy among women in selected communities of Ebonyi State, Nigeria.
    Akpa CO; Akinyemi JO; Umeokonkwo CD; Bamgboye EA; Dahiru T; Adebowale AS; Ajayi IO
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):457. PubMed ID: 31791271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are rural pregnant women disadvantaged in accessing intermittent preventive treatment in pregnancy in Ebonyi State, Nigeria?
    Akpa CO; Azuogu BN; Akpa WC; Umeokonkwo CD; Denwigwe CP; Azuogu VC; Agu AP; Ogah OE; Akamike IC; Ituma IB; Umeokonkwo AA; Onah CK; Adeke AS; Usuwa IS; Ogbonnaya LU; Ossai EN; Alo C; Onwasigwe C; Uzochukwu BS
    PLoS One; 2022; 17(11):e0269305. PubMed ID: 36355851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
    Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria.
    Diala CC; Pennas T; Marin C; Belay KA
    Malar J; 2013 Sep; 12():342. PubMed ID: 24059757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Workers' Awareness and Knowledge of Current Recommendation of Intermittent Preventive Treatment in Pregnancy in South-Western Nigeria.
    Bello OO; Oni O
    Ethiop J Health Sci; 2020 Jan; 30(1):125-134. PubMed ID: 32116441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.